OFEV® (nintedanib) time to face IPF head on Expanding horizons with then differentiated value of OFEV Document ID: PC-ZA-102013 05/05/2023 Author: Boehringer Ingelheim Reduced risk of Exacerbations and improved quality of Life RELATED CONTENT PC-ZA-102013 Production date: May 2023
